“Cell therapy has opened new possibilities in the treatment of both type
“Cell therapy has opened new possibilities in the treatment of both type
“Cell therapy has opened new possibilities in the treatment of both type 1 and type 2 diabetes. For type 1 diabetes, where the immune system attacks insulin-producing beta cells, stem cell therapy has the potential to regenerate these critical cells in the pancreas, restoring the body's ability to produce insulin naturally. Early clinical trials are already showing that patients treated with stem cells are experiencing better blood sugar control and reduced dependence on insulin injections.
Diabetes is a global public health crisis that threatens the economies of all nations. There are 2 primary forms of diabetes, insulin-dependent (IDDM) or type-1 and non-insulin-dependent (NIDDM) or type-2. In Type-1 DM there is a deficit of insulin caused by autoimmune destruction of β-cells. Therefore the only treatment in the type-1 DM is exogenous administration of insulin or beta-cell transplantation. On the other hand in the Type-2 DM, which is also the most commonest diabetes phenotype, there is inherent insulin resistance of peripheral tissues, which indirectly leads to insulin depletion in the latter stages.